Cash from Financing (Quarterly) Chart

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2012. Start Trial.
Date Value
June 30, 2026 0.9533M
March 31, 2026 0.6857M
December 31, 2025 0.3911M
September 30, 2025 0.306M
June 30, 2025 0.333M
March 31, 2025 0.323M
December 31, 2024 -0.6399M
September 30, 2024 0.056M
June 30, 2024 0.0346M
March 31, 2024 0.6043M
December 31, 2023 -0.0019M
September 30, 2023 0.0602M
June 30, 2023 0.0307M
March 31, 2023 -1.997M
December 31, 2022 0.3468M
September 30, 2022 0.0651M
June 30, 2022 -0.2687M
March 31, 2022 0.1252M
December 31, 2021
September 30, 2021 0.111M
June 30, 2021 0.077M
March 31, 2021 0.13M
December 31, 2020
September 30, 2020 0.0646M
June 30, 2020 0.0092M
Date Value
March 31, 2020 0.0012M
December 31, 2019 0.0419M
September 30, 2019 -0.007M
June 30, 2019 0.00
March 31, 2019 0.007M
December 31, 2018
September 30, 2018
June 30, 2018
March 31, 2018 0.061M
December 31, 2017
September 30, 2017
June 30, 2017
March 31, 2017
December 31, 2016
September 30, 2016 0.00
June 30, 2016 0.011M
March 31, 2016 0.0001M
December 31, 2015
September 30, 2015 -0.0021M
June 30, 2015 -0.0019M
March 31, 2015 0.004M
December 31, 2014 0.0009M
September 30, 2014 0.0035M
June 30, 2014 0.0052M
March 31, 2014 0.0787M

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks
Start Trial
PD-Rx Pharmaceuticals, Inc. --
Acro Biomedical Co. Ltd. 0.0103M
DataMeds AI, Inc. 5.541M
Interpace Biosciences, Inc. 0.00
Medical Marijuana, Inc. -0.7694M